| scholarly article | Q13442814 |
| P50 | author | Paul S. Gaynon | Q89543105 |
| Les Robison | Q91435233 | ||
| Xiao-Ou Shu | Q67482510 | ||
| P2093 | author name string | E Boyle | |
| Y Shao | |||
| S Bhatia | |||
| H N Sather | |||
| M Steinbuch | |||
| J P Perentesis | |||
| J Envall-Fox | |||
| W Kiffmeyer | |||
| P2860 | cites work | Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias | Q68123349 |
| Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881 | Q73330878 | ||
| Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology | Q73446189 | ||
| Analysis of RAS oncogene mutations in human lymphoid malignancies | Q24643802 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| RAS and leukemia: from basic mechanisms to gene-directed therapy | Q33539857 | ||
| Targeted therapies for high-risk acute myeloid leukemia | Q34417569 | ||
| Residential exposure to magnetic fields and acute lymphoblastic leukemia in children | Q34741245 | ||
| Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program | Q34832940 | ||
| Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia | Q36620750 | ||
| N-ras mutations in human cutaneous melanoma from sun-exposed body sites. | Q36770363 | ||
| Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation | Q37739922 | ||
| ras oncogenes: their role in neoplasia | Q37819681 | ||
| Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure | Q38463055 | ||
| Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about | Q40745421 | ||
| Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia | Q40968306 | ||
| All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. | Q42661182 | ||
| Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group | Q43863900 | ||
| Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer | Q44180779 | ||
| Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study | Q44405259 | ||
| Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells | Q46486969 | ||
| Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. | Q50871661 | ||
| Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. | Q53497397 | ||
| Parental cigarette smoking and the risk of acute leukemia in children | Q57268449 | ||
| Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy | Q64225643 | ||
| P433 | issue | 4 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 685-692 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia | |
| P478 | volume | 18 |
| Q41660964 | Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia |
| Q39437389 | Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis |
| Q41535044 | Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia. |
| Q36866417 | BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors |
| Q34143049 | Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia |
| Q89777602 | Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice |
| Q38779952 | Current status and future directions of T-lymphoblastic lymphoma in children and adolescents |
| Q36273532 | Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype |
| Q54780496 | Frequency of FLT3 mutations in childhood acute lymphoblastic leukemia. |
| Q41407670 | Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival |
| Q33787772 | Growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line |
| Q37268926 | High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia |
| Q42733616 | High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia. |
| Q35208383 | High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling |
| Q36105608 | IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias |
| Q36442504 | Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial |
| Q54406965 | Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil. |
| Q49787961 | Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia |
| Q53641321 | K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements. |
| Q36941105 | K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors |
| Q35220417 | Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group |
| Q36800426 | Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia |
| Q38771110 | Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. |
| Q34052520 | Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia |
| Q47884832 | Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia |
| Q53796172 | Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia. |
| Q46971359 | Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. |
| Q46799049 | Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia |
| Q52593673 | New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. |
| Q36947793 | Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation |
| Q82482903 | Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma |
| Q39992854 | Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes |
| Q48153742 | Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia |
| Q46519927 | RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia |
| Q27852887 | RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures |
| Q28250360 | RAS oncogenes: weaving a tumorigenic web |
| Q47875530 | RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia |
| Q34202697 | Ras in cancer and developmental diseases |
| Q34580110 | Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition |
| Q38227885 | Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting |
| Q91874414 | Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q91564481 | Synthetic modeling reveals HOXB genes are critical for the initiation and maintenance of human leukemia |
| Q98156928 | T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? |
| Q36352506 | Targeting oncogenic Ras signaling in hematologic malignancies |
| Q48188689 | The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia |
| Q38460308 | The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia. |
| Q56378380 | Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update |
| Q40213288 | Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children with Acute Lymphoblastic Leukemia |
Search more.